new
approach
urgent
need
evalu
potenti
hazard
pose
exposur
nanomateri
gene
express
profil
provid
inform
potenti
mode
action
human
relev
tool
recent
becom
avail
pathwaybas
quantit
risk
assess
object
studi
use
toxicogenom
context
human
health
risk
assess
explor
util
toxicogenom
risk
assess
use
publish
gene
express
data
mice
expos
g
printex
carbon
black
nanoparticl
cbnp
analysi
cbnpperturb
pathway
network
transcript
factor
reveal
concomit
chang
predict
phenotyp
eg
pulmonari
inflamm
genotox
correl
dose
time
benchmark
dose
bmd
apic
endpoint
compar
minimum
bmd
relev
pathwayspecif
express
chang
comparison
inflammatori
lung
diseas
model
ie
allerg
airway
inflamm
bacteri
infect
tissu
injuri
fibrosi
human
diseas
profil
reveal
induc
gene
express
chang
printex
expos
mice
similar
typic
pulmonari
injuri
fibrosi
similar
fibrot
pathway
perturb
cbnpexpos
mice
human
fibrosi
diseas
model
synthesi
demonstr
toxicogenom
profil
may
use
human
health
risk
assess
nanoparticl
constitut
import
step
forward
ultim
recognit
toxicogenom
endpoint
human
health
risk
knowledg
molecular
pathway
doserespons
characterist
relev
human
diseas
continu
grow
anticip
toxicogenom
becom
increasingli
use
assess
chemic
toxic
human
health
risk
assess
crown
chronic
inhal
fine
ultrafin
particul
matter
associ
advers
pulmonari
effect
includ
fibrosi
cancer
well
exacerb
exist
condit
asthma
bronchiti
chronic
obstruct
pulmonari
disord
bonner
knaapen
et
al
addit
cardiovascular
diseas
dockeri
et
al
pope
et
al
human
exposur
manufactur
nanomateri
nm
least
one
size
dimens
less
nm
may
constitut
increas
risk
advers
effect
especi
follow
inhal
exposur
potenti
induc
toxic
effect
poorli
understood
handi
shaw
moreov
human
health
risk
associ
inhal
exposur
adequ
investig
method
effect
screen
nm
toxic
paramount
due
countless
variat
physic
chemic
properti
nm
term
size
shape
agglomer
surfac
coat
tradit
assay
use
human
health
risk
assess
hhra
gener
involv
chronic
subchron
rodent
exposur
concomit
analys
tumour
induct
eg
twoyear
rodent
cancer
bioassay
addit
variou
noncanc
endpoint
sensit
use
regulatori
decisionmak
meek
et
al
approach
form
foundat
chemic
regulatori
system
invalu
hhra
howev
assay
base
chronic
anim
exposur
maximum
toler
dose
time
resourc
intens
thu
limit
broad
applic
suter
et
al
recent
discuss
identifi
gene
express
profil
potenti
rapid
costeffect
approach
identifi
assess
prospect
hazard
character
chemic
particl
mode
action
assess
human
relev
support
hhra
nation
academi
scienc
order
gene
express
data
becom
accept
routin
use
hhra
necessari
demonstr
mrnaprotein
express
profil
effect
predict
mode
action
biolog
outcom
exposur
relev
dose
confirm
data
use
strengthen
foundat
hhra
regulatori
decis
regard
hypothes
gene
express
profil
extrem
use
identifi
effect
low
dose
moreov
use
distinguish
dose
elicit
adapt
respons
vs
yield
advers
effect
boverhof
zacharewski
date
applic
gene
express
profil
regulatori
toxicolog
larg
focus
qualit
identif
chemic
mode
action
transcript
biomark
predict
specif
toxic
howev
util
gene
express
profil
quantit
determin
threshold
valu
eg
benchmark
dose
yet
rigor
explor
present
studi
investig
util
gene
express
profil
deriv
mice
expos
printex
carbon
black
nanoparticl
cbnp
intratrach
instal
identifi
potenti
hazard
mode
action
dose
advers
effect
may
expect
specif
toxicolog
outcom
addit
quantit
compar
benchmark
dose
pathway
apic
endpoint
deriv
experiment
anim
employ
printex
model
nm
due
rich
databas
tradit
toxic
inform
find
anchor
briefli
printex
consist
almost
entir
carbon
low
level
impur
term
polycycl
aromat
hydrocarbon
endotoxin
bourdon
et
al
jacobsen
et
al
saber
et
al
gener
reactiv
oxygen
speci
jacobsen
et
al
induc
dna
strand
break
vitro
vivo
jacobsen
et
al
saber
et
al
mutat
vitro
jacobsen
et
al
associ
oxid
stress
data
studi
previous
publish
experi
investig
printex
cbnp
exposur
mice
variou
dose
ie
vehicl
g
collect
sever
timepoint
day
follow
singl
acut
instil
bourdon
et
al
previous
character
widespread
chang
gene
express
involv
acut
phase
respons
inflamm
support
concomit
influx
pulmonari
bronchoalveolar
lavag
cell
bal
increas
tissuespecif
dna
strand
break
bourdon
et
al
b
addit
examin
bmd
bmdl
compar
cbnpmodifi
gene
express
profil
variou
model
lung
diseas
mice
human
report
literatur
order
explor
util
data
predict
potenti
risk
advers
health
outcom
human
relev
express
chang
work
demonstr
one
approach
gene
express
profil
may
integr
hhra
support
predict
apic
toxicolog
endpoint
doserespons
relev
human
diseas
detail
mous
exposur
particl
character
pulmonari
phenotyp
previous
publish
bourdon
et
al
b
briefli
femal
mice
expos
singl
instal
vehicl
printex
g
euthan
day
postexposur
n
intratrach
instil
rout
exposur
allow
deposit
known
dose
directli
lung
mice
control
potenti
dermaland
ingestionrel
cbnp
exposur
occur
whole
bodi
inhal
exposur
dose
select
repres
work
day
exposur
occup
inhal
exposur
limit
mgm
cb
establish
us
occup
safeti
health
administr
osha
us
nation
institut
occup
safeti
health
niosh
mous
assum
lh
inhal
rate
particl
deposit
mous
h
work
day
dybe
et
al
jacobsen
et
al
limit
filtrat
cbnp
nose
expect
human
exposur
printex
cbnp
character
display
follow
properti
nm
primari
particl
size
g
brunauer
emmett
teller
bet
surfac
area
gg
pah
eug
endotoxin
polydispers
index
mv
zeta
potenti
peak
hydrodynam
number
peak
volumesizedistribut
bourdon
et
al
analysi
pulmonari
inflammatori
cellular
influx
bronchoalveolar
lavag
bal
reveal
neutrophil
inflamm
sustain
day
dose
tissuespecif
genotox
observ
dna
strand
break
persist
day
two
highest
dose
fpgsensit
site
dose
day
highest
dose
day
bourdon
et
al
whole
mous
genom
dna
microarray
reveal
differenti
express
gene
fdr
adjust
pvalu
fold
chang
overal
lung
liver
respect
bourdon
et
al
complet
microarray
dataset
avail
gene
express
omnibu
ncbi
http
wwwncbinlmnihgovgeo
superseri
subseri
dataset
previous
use
examin
molecular
interact
lung
liver
upon
cbnp
exposur
bourdon
et
al
determin
affect
process
cbnp
exposur
pathway
analysi
gene
express
data
conduct
use
rank
base
test
r
r
develop
core
team
describ
alvo
et
al
rel
express
gene
pathway
first
align
subtract
median
express
valu
combin
treatment
control
group
valu
rank
within
subject
vector
averag
rank
calcul
treatment
group
distanc
two
treatment
calcul
permut
analysi
use
obtain
pvalu
pathway
pathway
p
consid
signific
benchmark
dose
bmd
lower
confid
limit
benchmark
dose
bmdl
calcul
apic
endpoint
rtpcr
data
bmd
repres
excess
risk
expos
anim
vs
control
bmdl
confid
limit
calcul
apic
endpoint
data
inflamm
genotox
rtpcr
use
epa
bmd
davi
et
al
data
statist
control
level
p
least
two
dose
includ
prior
run
analysi
data
screen
homogen
varianc
fit
five
continu
doserespons
model
ie
hill
polynomi
linear
power
exponenti
good
fit
scale
residu
within
appli
cut
select
appropri
model
curv
also
inspect
visual
one
model
suitabl
one
lowest
akaik
inform
criterion
aic
select
order
determin
bmd
bmdl
gene
express
data
bmdexpress
employ
briefli
microarray
probe
one
represent
array
averag
analys
perform
gene
identifi
statist
signific
oneway
anova
p
use
four
follow
model
hill
power
linear
polynomi
power
model
power
restrict
select
linear
polynomi
base
choos
model
describ
data
least
complex
nest
chisquar
test
cutoff
first
select
among
linear
polynomi
model
follow
compar
aic
measur
rel
good
fit
hill
model
exclud
k
paramet
model
less
lowest
posit
dose
g
black
et
al
set
includ
maximum
iter
confid
level
benchmark
respons
bmr
number
standard
deviat
defin
bmd
function
classif
analys
result
bmd
dataset
map
kegg
pathway
promiscu
probe
remov
probe
map
multipl
annot
gene
bmd
exceed
highest
exposur
dose
g
exceed
goodnessoffit
pvalu
remov
analysi
determin
correl
gene
express
profil
mice
expos
cbnp
mous
pulmonari
diseas
model
predict
analysi
microarray
pam
tibshirani
et
al
conduct
r
r
develop
core
team
use
pamr
librari
hasti
et
al
data
analysi
encompass
mous
lung
diseas
model
obtain
nation
centr
biotechnolog
inform
gene
express
omnibu
access
sampl
label
belong
one
three
model
lung
inflamm
bacteri
infect
lung
injuri
fibrosi
respons
allerg
airway
inflamm
probe
common
genbank
access
collaps
singl
measur
sampl
use
mean
use
common
access
number
predict
model
use
shrunken
centroid
estim
crossvalid
nearest
shrunken
centroid
classifi
conduct
identifi
appropri
threshold
pamr
implement
crossvalid
involv
divid
sampl
ten
approxim
equals
part
ensur
class
distribut
proport
tenfold
crossvalid
work
fit
model
sampl
predict
class
label
remain
procedur
repeat
ten
time
part
play
role
test
sampl
error
ten
part
ad
togeth
comput
overal
error
threshold
select
yield
classifi
genbank
access
mean
nine
cbnp
treatment
condit
classifi
use
estim
predict
model
function
analysi
conduct
establish
molecular
perturb
common
discrep
cbnp
expos
mice
inflammatori
lung
diseas
model
analysi
conduct
gene
common
cbnp
lung
diseas
model
gene
uniqu
cbnp
use
cutoff
fdradjust
p
foldchang
dataset
less
stringent
cutoff
employ
diseas
model
low
power
sever
dataset
david
bioinformat
resourc
use
identifi
enrich
biolog
function
term
similar
gene
biolog
mean
huang
et
al
b
david
biolog
function
enrich
score
consid
signific
accord
david
recommend
huang
et
al
cluster
enrich
score
analysi
contain
least
one
gene
ontolog
term
pathway
benjaminicorrect
pvalu
order
predict
potenti
diseas
outcom
relev
human
gene
express
profil
mine
genom
data
repositori
diseas
predict
analysi
done
nextbio
http
nextbiocom
use
high
dose
exposur
profil
differenti
express
gene
identifi
timepoint
dose
data
cbnp
expos
mice
compar
curat
dataset
identifi
diseas
studi
similar
gene
profil
gene
rank
consist
pairwis
gene
signatur
correl
rankbas
enrich
statist
employ
calcul
nextbio
score
diseas
diseas
rank
highest
comparison
cbnp
exposur
given
score
rest
result
normal
accordingli
kupershmidt
et
al
metaanalysi
perform
use
select
diseas
model
mice
well
human
studi
repres
diseas
state
analysi
identifi
rank
score
gene
biogroup
common
studi
accord
score
method
describ
diseas
predict
kupershmidt
et
al
biogroup
filter
canon
pathway
rankbas
pathway
analysi
reveal
total
differenti
express
kegg
pathway
day
respect
affect
pathway
accord
statist
signific
primarili
relat
inflamm
day
steroid
biosynthesi
dna
repair
day
apoptosi
inflamm
day
signific
pathway
p
pertain
genotox
dna
damag
repair
inflammatori
immun
respons
summar
tabl
along
previous
establish
phenotyp
signific
pathway
present
supplement
tabl
analysi
number
common
pathway
dose
timepoint
reveal
pathway
occur
lower
dose
also
occur
higher
dose
howev
number
signific
pathway
increas
dose
fig
epa
bmd
bmd
bmdl
gener
apic
endpoint
rtpcr
data
bmd
valu
endpoint
gene
present
supplementari
tabl
curv
present
supplement
fig
although
mani
apic
endpoint
rtpcr
data
suitabl
model
bmd
bmdl
valu
gener
increas
postexposur
time
expect
mean
bmd
inflammatori
apic
endpoint
g
bmdl
g
day
respect
bmd
valu
rtpcr
data
gene
involv
inflamm
tend
higher
apic
endpoint
mean
bmd
inflammatori
gene
g
mean
bmdl
g
day
respect
bmd
bmdl
also
gener
microarray
gene
express
profil
use
bmdexpress
minimum
bmd
kegg
pathway
relev
inflamm
kegg
pathway
relev
genotox
sensit
kegg
pathway
well
apic
endpoint
data
present
tabl
minimum
bmd
calcul
accord
median
signific
gene
pathway
percentil
signific
gene
pathway
order
increas
sensit
even
percentil
bmd
tend
higher
bmd
gener
apic
endpoint
tabl
howev
minimum
bmd
repres
sensit
gene
relev
pathway
much
compar
bmd
apic
endpoint
tabl
pam
use
compar
printex
gene
express
dataset
pulmonari
gene
express
profil
repres
rang
murin
pulmonari
diseas
model
eg
transgen
overexpress
treatment
infecti
agent
toxic
chemic
allergen
describ
lewi
et
al
thomson
et
al
model
classifi
accord
three
follow
subgroup
bacteri
infect
lung
injuri
fibrosi
respons
allerg
airway
inflamm
cluster
model
use
pam
shown
fig
two
cbnp
exposur
condit
day
low
medium
dose
cluster
cbnp
exposur
condit
diseas
model
like
due
lack
respons
model
bacteri
infect
cluster
diseas
model
cbnp
exposur
pam
analysi
reveal
associ
cbnp
exposur
respons
lung
injuryfibrot
respons
although
respons
lung
injuryfibrot
respons
close
associ
one
anoth
cbnp
exposur
pam
analysi
reveal
cbnp
exposur
close
relat
lung
injuryfibrot
respons
respons
also
support
probabl
statist
compar
cbnp
exposur
diseas
subgroup
fig
order
examin
common
discrep
diseas
model
cbnp
exposur
detail
function
analysi
conduct
gene
common
cbnp
diseas
model
gene
uniqu
cbnp
number
signific
gene
use
analysi
present
supplement
tabl
david
biolog
function
summar
tabl
analysi
demonstr
inflamm
common
model
timepoint
exclud
aspergillu
extract
day
common
cbnp
exposur
observ
bacteri
infect
model
ie
due
acut
phase
respons
injuri
fibrosi
model
ie
due
chang
tissu
morphogenesi
relat
gene
day
reveal
inflamm
cell
cycl
disturb
model
howev
cbnp
respons
similar
bleomycininduc
lung
injuri
shown
high
degre
overlap
biolog
function
day
tabl
cbnp
trigger
adapt
immun
respons
day
also
appar
lung
injuri
fibrosi
model
gene
express
profil
high
dose
cbnpexpos
mice
vs
control
analys
nextbio
identifi
close
relat
respiratori
diseas
profil
human
postexposur
day
sever
acut
respiratori
syndrom
sar
congenit
cystic
tabl
summari
signific
kegg
pathway
p
relat
phenotyp
establish
bourdon
et
al
b
venn
diagram
illustr
overlap
signific
pathway
p
accord
dose
postexposur
day
day
mice
expos
cbnp
adenomatoid
malform
injuri
lung
identifi
top
three
respiratori
diseas
associ
cbnp
exposur
interestingli
fibrosi
identifi
predict
diseas
outcom
cbnp
exposur
increas
consider
time
eg
score
day
day
day
order
examin
molecular
mechan
may
involv
fibrosi
detail
metaanalysi
complet
use
curat
studi
within
nextbio
identifi
fibrosi
phenotyp
metaanalysi
mous
employ
model
includ
fibrosisinduc
injuri
naphthalen
bleomycin
ganciclovir
doxycyclineinduc
overexpress
overexpress
varieti
mous
model
wild
type
inflamm
resistantsuscept
metaanalysi
use
cbnp
gene
express
profil
mous
rank
canon
pathway
gene
present
least
one
studi
select
model
pulmonari
fibrosi
lung
injuri
identifi
nextbio
diseas
correl
profil
order
establish
humanrelev
analysi
repeat
use
human
studi
curat
nextbio
metaanalysi
encompass
studi
lung
biopsi
patient
affect
fibrosi
intermedi
sever
pulmonari
hypertens
pneumonia
exacerb
idiopath
pulmonari
fibrosi
overal
canon
pathway
gene
rank
present
least
one
studi
top
rank
pathway
gene
mous
human
metaanalys
present
tabl
interestingli
comparison
foldrank
mous
human
analysi
reveal
affect
pathway
speci
howev
gene
perturb
fibrot
respons
consider
differ
cbnpexpos
mice
compar
human
diseas
except
dehydrogenas
kruppellik
factor
secret
phosphoprotein
ceruloplasmin
cp
wide
accept
toxic
preced
accompani
transcript
chang
thu
provid
molecular
signatur
direct
indirect
toxic
effect
auerbach
et
al
fielden
et
al
gatzid
et
al
hypothes
toxicogenom
profil
use
screen
tool
priorit
specif
assay
conduct
standard
batteri
test
thu
minim
anim
use
cost
time
dix
et
al
moreov
global
analys
transcript
chang
provid
wealth
inform
use
identifi
put
mode
action
queri
relev
human
advers
health
outcom
curri
type
approach
gener
premis
wide
support
paradigm
outlin
toxic
test
centuri
nation
academi
scienc
howev
substant
work
demonstr
abil
gene
express
profil
identifi
hazard
assess
risk
exposur
via
quantit
doserespons
analysi
identifi
advers
outcom
associ
specif
mode
action
requir
endpoint
use
hhra
present
studi
appli
pathwayand
networkbas
approach
bmd
model
diseas
predict
tool
gene
express
data
explor
relationship
apic
endpoint
transcript
profil
work
investig
potenti
util
gene
express
profil
determin
hazard
mode
action
np
character
doserespons
relationship
predict
relev
find
potenti
diseaseoutcom
human
health
effect
hhra
util
gene
express
profil
hazard
identif
examin
limit
number
chemic
includ
dibutyl
phthalat
acetaminophen
eul
et
al
kienhui
et
al
makri
et
al
toxicogenom
profil
alachlor
exposur
rat
olfactori
mucosa
genter
et
al
dimethylarsen
dma
exposur
human
cultur
bladder
cell
rat
bladder
epithelium
sen
et
al
us
epa
also
tabl
comparison
cbnp
profil
lung
diseas
model
use
function
analysi
gene
common
grey
gene
uniqu
cbnp
black
provid
use
inform
two
final
assess
acetochlor
arsen
us
epa
data
demonstr
gene
express
profil
also
view
effect
predictor
biolog
effect
cbnp
exposur
exampl
inflammatori
respons
manifest
gene
express
level
detect
use
dna
microarray
classifi
work
use
kegg
pathway
analys
previous
mice
use
ingenu
pathway
analysi
bourdon
et
al
entir
consist
observ
pulmonari
influx
inflammatori
marker
eg
neutrophil
eosinophil
lymphocyt
number
gene
perturb
magnitud
express
chang
pathway
correl
dose
time
addit
observ
transcriptom
chang
associ
perturb
cell
cycl
network
alter
nonhomolog
endjoin
signal
support
sustain
genotox
observ
mice
although
dose
time
correl
appar
eg
level
dna
strand
break
remain
rel
constant
two
highest
exposur
dose
bourdon
et
al
wherea
induct
dna
repair
gene
decreas
dose
time
transcriptom
chang
associ
alter
glutathion
metabol
free
radic
scaveng
correl
induct
dna
formamidopyrimidin
dna
glycoslas
fpg
sensit
site
indic
oxid
dna
damag
earli
exposur
persist
respons
indic
adapt
respons
oxid
stress
lung
mice
interestingli
cbnpinduc
alter
gene
express
profil
also
reveal
pulmonari
acut
phase
respons
unexpect
chang
lipid
homeostasi
subsequ
support
measur
decreas
plasma
high
densiti
lipoprotein
hdl
bourdon
et
al
strong
associ
cbnpinduc
gene
express
profil
apic
endpoint
collect
support
use
toxicogenom
hazard
identif
tabl
metaanalys
nextbio
use
mous
human
profil
fibrosi
phenotyp
valu
parenthes
repres
rank
opposit
speci
mous
human
rank
rank
pathway
rank
rank
gene
symbol
nm
perhap
importantli
highlight
unexpect
advers
outcom
moreov
ongo
work
within
organ
econom
cooper
develop
oecd
activ
develop
advers
outcom
pathway
aop
approach
expect
provid
tangibl
method
system
biolog
endpoint
use
human
health
risk
assess
toxicogenom
data
examin
respons
dose
time
varieti
tissu
use
applic
illustr
cbnp
exposur
fig
overal
data
suggest
gene
express
profil
effect
use
identifi
put
mode
action
hazard
np
exposur
absenc
phenotyp
data
addit
identif
hazard
suggest
gene
express
profil
may
use
quantit
assess
eg
establish
refer
dose
respons
relat
cancer
noncanc
endpoint
benchmark
dose
gener
consid
inform
observ
advers
effect
level
noael
deriv
refer
dose
base
entir
doserespons
relationship
crump
et
al
alter
gene
express
initi
absenc
biolog
effect
eg
adapt
stress
respons
pathway
effect
mitig
toxic
effect
expect
refer
dose
genom
endpoint
may
sensit
use
hhra
howev
previou
analys
chemic
ie
propylen
glycol
monotbutyl
ether
methylen
chlorid
naphthalen
show
median
bmd
bmdl
sensit
pathway
go
categori
highli
correl
bmd
bmdl
cancer
noncanc
endpoint
thoma
et
al
current
studi
rather
choos
sensit
ie
lowest
bmd
focuss
analysi
pathway
specif
biolog
outcom
observ
mice
ie
phenotyp
anchor
calcul
bmd
relev
gene
pathway
pathwaybas
bmd
bmdl
calcul
relev
pathway
actual
less
sensit
ie
higher
bmd
observ
apic
endpoint
howev
mean
minimum
bmd
bmdl
across
pathway
assign
relev
apic
endpoint
ie
correspond
sensit
gene
within
relev
pathway
similar
relev
apic
endpoint
median
bmd
bmdl
sensit
pathway
also
correl
close
apic
endpoint
even
though
pathway
necessarili
relev
endpoint
find
support
previou
exampl
demonstr
correl
bmd
gene
express
apic
endpoint
thoma
et
al
data
indic
potenti
util
use
gene
express
profil
determin
accept
exposur
limit
np
order
determin
specif
util
pathway
deriv
bmd
hhra
necessari
establish
comprehens
catalogu
pathway
actual
perturb
event
specif
advers
effect
perhap
princip
motiv
includ
gene
express
profil
hhra
wealth
inform
use
identifi
key
event
correl
advers
outcom
relev
human
diseas
moreov
use
predict
likelihood
human
diseas
identif
key
event
transcript
level
facilit
identif
process
critic
diseas
initi
progress
thu
allow
inform
anim
experi
queri
use
extrapol
human
scenario
edward
preston
comparison
data
specif
model
lung
diseas
includ
bacteri
infect
airway
hypersensit
lung
injuri
reveal
cbnp
induc
respons
close
relat
lung
injuri
fibrosi
model
find
support
comparison
express
profil
cbnp
expos
mice
curat
studi
anim
human
exhibit
myriad
pulmonari
diseas
phenotyp
analysi
demonstr
cbnp
exposur
perturb
gene
known
involv
tissu
injuri
fibrosi
mice
although
unclear
cbnp
exposur
would
result
gene
express
profil
human
similar
pathway
includ
mani
involv
fibrot
respons
found
mice
human
top
pathway
found
common
mous
human
despit
concord
pathway
top
rank
gene
differ
consider
speci
howev
mani
gene
found
mice
human
similar
function
includ
inflammatori
acut
phase
respons
eg
mice
cp
human
cell
cycl
progress
mice
human
bone
tissu
model
eln
ogn
mice
human
thu
despit
discord
gene
express
profil
speci
similar
function
top
rank
gene
concord
pathway
support
likelihood
similar
respons
event
cbnp
exposur
human
addit
fibrosi
identifi
outcom
exposur
variou
particl
np
anim
bermudez
et
al
shvedova
et
al
includ
printex
eg
nose
inhal
wistar
wu
rat
bellmann
et
al
well
human
lkhasuren
et
al
wang
christiani
process
pulmonari
fibrosi
close
relat
progress
carcinogen
outcom
hubbard
et
al
data
demonstr
similar
fibrot
pathway
mice
human
signific
overlap
cbnpinduc
gene
express
chang
thu
support
use
pathwaybas
approach
identifi
molecular
mechan
diseas
onset
progress
use
gene
express
profil
support
hhra
studi
confirm
sever
key
element
necessari
applic
gene
express
profil
hhra
toxic
exposur
gener
first
transcript
profil
effect
predict
biolog
effect
chemic
exposur
specif
absenc
data
apic
endpoint
data
would
suggest
mice
expos
cbnp
exhibit
inflammatori
respons
oxid
stress
dna
damag
perturb
cholesterol
metabol
second
comparison
bmd
bmdl
relev
pathway
apic
endpoint
confirm
minimum
pathway
bmd
bmdl
rang
apic
endpoint
third
express
profil
fairli
easili
mine
identifi
potenti
advers
outcom
ie
diseas
relev
human
might
reason
expect
occur
human
expos
substanc
elicit
specif
gene
express
pattern
experiment
anim
believ
work
constitut
signific
step
toward
ultim
recognit
toxicogenom
endpoint
routin
assess
human
health
risk
gene
express
profil
offer
promis
approach
deciph
larg
unknown
hazard
np
exposur
due
uniqu
properti
np
power
technolog
assess
multitud
advers
outcom
possibl
requir
elucid
mode
action
potenti
impact
human
health
within
timefram
suitabl
prompt
regulatori
decis
make
premis
hold
true
new
chemic
product
toxic
larg
complet
unknown
order
establish
strong
foundat
integr
gene
express
profil
hhra
necessari
approach
employ
appli
varieti
addit
chemicalsparticl
span
wide
rang
toxicolog
potenc
mode
action
use
varieti
experiment
design
eg
multipl
dose
timepoint
knowledg
molecular
pathway
divers
tool
use
deciph
biolog
signific
doserespons
characterist
relev
human
diseas
continu
grow
anticip
toxicogenom
becom
increasingli
use
assess
toxicolog
hazard
wide
rang
test
articl
extens
hhra
marchetti
lynn
berndtwei
miriam
hill
health
canada
thank
review
comment
origin
manuscript
work
support
health
canada
genom
research
develop
initi
chemic
manag
plan
financi
support
j
bourdon
natur
scienc
engin
research
council
canada
